WebAug 31, 2024 · Drug: Cisplatin. Phase 2. Detailed Description: Transcatheter arterial chemoembolization (TACE) has been playing an important role in the treatment algorithm for patients with multifocal or large intrahepatic lesions not eligible for surgical resection, … WebTransarterial chemoembolization (TACE) is an accepted treatment method for HCC; however, it is a palliative, rather than curative, therapeutic option. 11,12 TACE usually involves chemotherapeutic agent injection followed by embolic material administration into the feeding arteries of the HCC. 11,12 In Japan, TACE has been performed using ...
Stability of cisplatin, doxorubicin, and mitomycin combined …
WebChemotherapy regimens used for TACE included: gemcitabine only (n=18), gemcitabine followed by cisplatin (n=2), gemcitabine followed by oxaliplatin (n=4), gemcitabine and cisplatin in combination (n=14), and gemcitabine and cisplatin followed by … WebMethods: We retrospectively assessed the clinical data of patients with liver metastases from uveal melanoma who received TACE therapy using cisplatin (70 mg/m 2) and gelatin sponge between 1997 and 2008. Results: We identified 29 eligible patients. The overall response rate was 21%. iphone 12 charging slow
Transarterial Chemoembolization With Cisplatin as …
WebApr 30, 2024 · Transarterial chemoembolization (TACE) has been the standard of care for treatment of intermediate-stage hepatocellular carcinoma (HCC) for the past 2 decades. Based on two randomized trials in 2002, TACE using doxorubicin or cisplatin and gelatin sponge demonstrated a survival benefit over best supportive care ( 1, 2 ). WebConclusion: TACE using miriplatin plus cisplatin was related to a prolonged survival, with comparable adverse effects of TACE using cisplatin alone. Background: Miriplatin is a slow-release, lipophilic platinum complex, developed to produce a superior antitumor effect for hepatocellular carcinoma (HCC). However, the miriplatin suspension is ... WebJun 25, 2024 · The TACL-ECF regimen comprised transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-FU. Of the 94 patients, 22 and 72 patients were in Barcelona Clinic Liver Cancer stages B and C, respectively; 66% patients were … iphone 12 cheap deals